Skip to main content
Clinical Trials/NCT05518227
NCT05518227
Terminated
Not Applicable

Patient Satisfaction and Visual Outcomes After Bilateral PanOptix Implantation in Patients With Previous Multifocal Contact Lens

Vivid Laser Center1 site in 1 country12 target enrollmentJanuary 19, 2023
ConditionsCataract

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cataract
Sponsor
Vivid Laser Center
Enrollment
12
Locations
1
Primary Endpoint
Satisfaction questionnaire
Status
Terminated
Last Updated
last year

Overview

Brief Summary

To evaluate spectacle independence and patient satisfaction and visual outcomes after bilateral PanOptix implantation in patients with previous multifocal contact lens experience.

Detailed Description

This study is a single-arm unmasked clinical evaluation study of patient satisfaction after successful bilateral cataract surgery. Subjects will be assessed pre-operatively, operatively and at 1 day, 1 week and 3 months post-operatively. Clinical evaluations will include administration of a visual disturbance questionnaire (QUVID), and a satisfaction questionnaire (IOLSAT), as well as measurement of bilateral visual acuity and manifest refraction.

Registry
clinicaltrials.gov
Start Date
January 19, 2023
End Date
July 24, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Vivid Laser Center
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subjects are eligible for the study if they meet the following criteria:
  • Note: Ocular criteria must be met in both eyes.
  • Adult cataract patients undergoing uncomplicated cataract surgery with Clareon PanOptix IOL implantation (non-toric/toric).
  • Visually significant cataracts bilaterally.
  • History of successful soft multifocal contact lens use in the past (within ≤ last 5 years).
  • Healthy ocular exam.
  • Gender: Males and Females.
  • Willing and able to provide written informed consent for participation in the study.
  • Willing and able to comply with scheduled visits and other study procedures.

Exclusion Criteria

  • If any of the following exclusion criteria are applicable to the subject or either eye, the subject should not be enrolled in the study.
  • Previous monovision patients.
  • Ocular comorbidity that might hamper post operative visual acuity (Uveitis, Keratoconus, Retinopathies, Glaucoma).
  • Previous ocular or refractive surgery.
  • Expected monocular post-op distance VA worse than 20/25 (Snellen) in either eye.
  • Refractive lens exchange.
  • Angle kappa measurement in a single eye over 0.6 mm.
  • Irregular corneal astigmatism or ectasia.
  • Difficulties comprehending written or spoken English language.
  • Patients with physical or intellectual disability (e.g. Down's Syndrome, Parkinson's Disease; unable to fixate).

Outcomes

Primary Outcomes

Satisfaction questionnaire

Time Frame: 3 months postoperative

The Intraocular Lens Satisfaction questionnaire (IOLSAT). Lower scores indicate higher spectacle independence and satisfaction.

Secondary Outcomes

  • Binocular uncorrected distance visual acuity (6m)(3 months postoperative)
  • Binocular uncorrected intermediate visual acuity (60 cm)(3 months postoperative)
  • Binocular distance corrected intermediate visual acuity (40 cm)(3 months postoperative)
  • Manifest refraction(3 months postoperative)
  • Spectacle independence(3 months postoperative)
  • Binocular uncorrected near visual acuity (40 cm)(3 months postoperative)
  • Binocular corrected distance visual acuity (6m)(3 months postoperative)
  • Binocular distance corrected intermediate visual acuity (60 cm)(3 months postoperative)

Study Sites (1)

Loading locations...

Similar Trials